Symbicort steroid weight gain

Although the risk of developing hypothalamic-pituitary-adrenal (HPA) suppression is very low with inhaled budesonide; formoterol, patients should, nevertheless, be monitored for this possibility. Particular care is needed for patients who are transferred from systemic to inhaled corticosteroids because deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic to less systemically absorbed inhaled corticosteroids. Patients previously maintained on doses equivalent to greater than or = 20 mg/day of prednisone may be at increased risk. After withdrawal from systemic corticosteroids, a number of months are required for recovery of HPA-axis function.

Symbicort steroid weight gain

symbicort steroid weight gain

Media:

symbicort steroid weight gainsymbicort steroid weight gainsymbicort steroid weight gainsymbicort steroid weight gainsymbicort steroid weight gain

http://buy-steroids.org